You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 4,062,942

✉ Email this page to a colleague

Summary for Patent: 4,062,942

Title:	Induction of ovulation with partially desialylated human chorionic gonadotropin
Abstract:	Partially desialylated human Chorionic Gonadotropin is used after menotropin administration to induce ovulation.
Inventor(s):	Donini; Pietro (Rome, IT)
Assignee:	Serono Laboratories, Inc. (Boston, MA)
Application Number:	05/658,490
Patent Claims:	1. In the method of inducing ovulation by the sequential administration of menotropins and human chorionic gonadotropin, the improvement which comprises employing partially desialylated human chorionic gonadotropin as said human chorionic gonadotropin, wherein said partially desialylated human chorionic gonadotropin has a degree of desialylation of 15 to 35%. 2. The method of claim 1 wherein said partially desialylated human chorionic gonadotropin is administered in an amount of 5000 I.U. human chorionic gonadotropin per day. 3. The method of claim 1 wherein said human chorionic gonadotropin is employed in the form of a saline solution of lyophilized partially desialylated human chorionic gonadotropin. 4. The method of claim 3 wherein said saline solution contains an excipient. 5. The method of claim 4 wherein said excipient is lactose.

Details for Patent 4,062,942

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	January 15, 1974	⤷ Get Started Free	1996-02-17
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	December 27, 1984	⤷ Get Started Free	1996-02-17
Ferring Pharmaceuticals Inc.	NOVAREL	chorionic gonadotropin	For Injection	017016	February 15, 1985	⤷ Get Started Free	1996-02-17
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.